This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (15)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Roger C. Bone, MD

Arch Intern Med. 1980;140(1):85-89.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Recently, advances have been made in the treatment of respiratory failure. One major advance is the use of oxygen as a drug with dose-related efficacy and toxicity. The other major advance is the augmentation of oxygen delivery to the tissue by methods other than increasing the oxygen dose. These new methods include mechanical ventilation and positive end-expiratory pressure (PEEP).

In 1967, Ashbaugh et al first described acute respiratory failure after civilian trauma. They coined the term "adult respiratory distress syndrome" (ARDS) and were the first to recommend PEEP as a treatment modality.¹ Acute lung injury resulting in ARDS can result from multiple causes including sepsis, diffuse aspiration pneumonia, shock, pancreatitis, fat embolism, and viral pneumonia.

The ARDS develops in approximately 150,000 patients annually.² The majority are young and previously had been healthy. Mortality may be greater than 75% in patients requiring an inspired oxygen concentration (F₁O . . . [Full Text PDF of this Article]

Author Affiliations
From the University of Arkansas Center for Health Sciences, Little Rock.

Footnotes
Accepted for publication April 6, 1979.

Reprint requests to Pulmonary Division, University of Arkansas Medical Center, VA Complex, 4301 W Markham, Little Rock, AR 72201 (Dr Bone).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?